Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Voglicare-M 0.3 Tablet ER

Prescription Icon
Prescription Required

Marketer

Care Formulation Labs Pvt Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview Voglicare-M 0.3 Tablet ER

Diabexe-M 0.3 Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose control. Diabexe-M 0.3 ER should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes. These are generally transient and self-limiting; however, persistent or concerning side effects warrant medical attention. Your doctor can offer strategies to mitigate or treat bothersome side effects. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or significant kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires prior physician consultation. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.

Uses of Voglicare-M 0.3 Tablet ER

Managing type 2 diabetes

Major Benefits of Voglicare-M 0.3 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Voglicare-M 0.3 Tablet ER whole; do not crush, chew, or break it. Administer this extended-release tablet with food.

Common Side effects of Voglicare-M 0.3 Tablet ER:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Voglicare-M 0.3 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or dividing it. Voglicare-M 0.3 mg Extended-Release Tablet should be administered with a meal.

How Voglicare-M 0.3 Tablet ER works:

Voglicare-M 0.3 Extended-Release tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Voglicare-M 0.3 Tablet ER and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Voglicare-M 0.3mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Voglicare-M 0.3mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Extended-release Voglicare-M 0.3mg tablets typically do not impair driving ability. Nevertheless, individuals taking this medication concurrently with other antidiabetic drugs like sulfonylureas, insulin, or repaglinide should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Voglicare-M 0.3 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Voglicare-M 0.3 Tablet ER use in individuals with hepatic impairment is scarce. Physician consultation is recommended.

What if you forget to take Voglicare-M 0.3 Tablet ER :

Should you forget a dose of Voglicare-M 0.3 Tablet ER, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglicare-M 0.3 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment
Voglicare-M 0.3 Tablet ER
79
MRP 96
17% off